172 related articles for article (PubMed ID: 21246238)
1. Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.
Chen YW; Chou HC; Lyu PC; Yin HS; Huang FL; Chang WS; Fan CY; Tu IF; Lai TC; Lin ST; Lu YC; Wu CL; Huang SH; Chan HL
Funct Integr Genomics; 2011 Jun; 11(2):225-39. PubMed ID: 21246238
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer.
Lo YW; Lin ST; Chang SJ; Chan CH; Lyu KW; Chang JF; May EW; Lin DY; Chou HC; Chan HL
J Cell Mol Med; 2015 Apr; 19(4):744-59. PubMed ID: 25639359
[TBL] [Abstract][Full Text] [Related]
3. Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.
Chang JF; Lin ST; Hung E; Lu YL; Soon May EW; Lo YW; Chou HC; Chan HL
Toxicol Sci; 2014 Jun; 139(2):396-406. PubMed ID: 24675091
[TBL] [Abstract][Full Text] [Related]
4. Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel.
Daniel P; Halada P; Jelínek M; Balušíková K; Kovář J
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248089
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
Xu SG; Yan PJ; Shao ZM
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis of Stage-II Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues.
Abdullah Al-Dhabi N; Srigopalram S; Ilavenil S; Kim YO; Agastian P; Baaru R; Balamurugan K; Choi KC; Valan Arasu M
Biomed Res Int; 2016; 2016():3071013. PubMed ID: 27110560
[TBL] [Abstract][Full Text] [Related]
7. HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer.
Cho SY; Kang S; Kim DS; Na HJ; Kim YJ; Choi YD; Cho NH
Anticancer Res; 2018 Nov; 38(11):6551-6560. PubMed ID: 30396985
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
[TBL] [Abstract][Full Text] [Related]
9. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
10. Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.
Liu Z; Xu S; Li L; Zhong X; Chen C; Fan Y; Shen W; Zu L; Xue F; Wang M; Zhou Q
Thorac Cancer; 2019 May; 10(5):1111-1128. PubMed ID: 30950202
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and glycative damage affect specific mitochondrial proteins with aging in rat liver.
Bakala H; Ladouce R; Baraibar MA; Friguet B
Biochim Biophys Acta; 2013 Dec; 1832(12):2057-67. PubMed ID: 23906978
[TBL] [Abstract][Full Text] [Related]
12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
14. Serum Proteomic Signatures of Male Breast Cancer.
Zografos E; Anagnostopoulos AK; Papadopoulou A; Legaki E; Zagouri F; Marinos E; Tsangaris GT; Gazouli M
Cancer Genomics Proteomics; 2019; 16(2):129-137. PubMed ID: 30850364
[TBL] [Abstract][Full Text] [Related]
15. [Identification of metastasis-associated proteins of ovarian cancer by proteomics].
Zhou L; Yang XF; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):814-8. PubMed ID: 18346353
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of breast cancer for marker discovery and signal pathway profiling.
Hondermarck H; Vercoutter-Edouart AS; Révillion F; Lemoine J; el-Yazidi-Belkoura I; Nurcombe V; Peyrat JP
Proteomics; 2001 Oct; 1(10):1216-32. PubMed ID: 11721634
[TBL] [Abstract][Full Text] [Related]
17. Principal component analysis on LC‑MS/MS and 2DE‑MALDI‑TOF in glioblastoma cell lines reveals that mitochondria act as organelle sensors of the metabolic state in glioblastoma.
Gómez-Caudillo L; Ortega-Lozano AJ; Martínez-Batallar ÁG; Rosas-Vargas H; Minauro-Sanmiguel F; Encarnación-Guevara S
Oncol Rep; 2020 Aug; 44(2):661-673. PubMed ID: 32468038
[TBL] [Abstract][Full Text] [Related]
18. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
19. Fungal proteomics: mapping the mitochondrial proteins of a Trichoderma harzianum strain applied for biological control.
Grinyer J; McKay M; Herbert B; Nevalainen H
Curr Genet; 2004 Mar; 45(3):170-5. PubMed ID: 14652694
[TBL] [Abstract][Full Text] [Related]
20. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
